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Background: Both compulsory detoxification treatment and community-based methadone maintenance treatment
(MMT) exist for heroin addicts in China. We aim to examine the effectiveness of three intervention models for
referring heroin addicts released from compulsory detoxification centers to community methadone maintenance
treatment (MMT) clinics in Dehong prefecture, Yunnan province, China.
Methods: Using a quasi-experimental study design, three different referral models were assigned to four
detoxification centers. Heroin addicts were enrolled based on their fulfillment to eligibility criteria and provision of
informed consent. Two months prior to their release, information on demographic characteristics, history of heroin
use, and prior participation in intervention programs was collected via a survey, and blood samples were obtained
for HIV testing. All subjects were followed for six months after release from detoxification centers. Multi-level logistic
regression analysis was used to examine factors predicting successful referrals to MMT clinics.
Results: Of the 226 participants who were released and followed, 9.7% were successfully referred to MMT(16.2% of
HIV-positive participants and 7.0% of HIV-negative participants). A higher proportion of successful referrals was
observed among participants who received both referral cards and MMT treatment while still in detoxification
centers (25.8%) as compared to those who received both referral cards and police-assisted MMT enrollment (5.4%)
and those who received referral cards only (0%). Furthermore, those who received referral cards and MMT
treatment while still in detoxification had increased odds of successful referral to an MMT clinic (adjusted OR = 1.2,
CI = 1.1-1.3). Having participated in an MMT program prior to detention (OR = 1.5, CI = 1.3-1.6) was the only baseline
covariate associated with increased odds of successful referral.
Conclusion: Findings suggest that providing MMT within detoxification centers promotes successful referral of
heroin addicts to community-based MMT upon their release.
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Heroin use and heroin-related HIV infections are import-
ant public health concerns in China, and heroin users rep-
resent a high-risk population critical to broader HIV
infection prevention efforts [1,2]. There are approximately
1.54 million illicit drug users registered by the China’s
Ministry of Public Security, the majority of whom (69%)
are heroin users [3]. In 1987, the first heroin detoxification
centers were established in in Lanzhou city, Gansu prov-
ince in southwestern China, where illicit drug use is rela-
tively common. As of 2010, approximately 216,000 drug
users were detained in detoxification centers across the
nation [3]. Drug users sentenced to a compulsory detoxifi-
cation center are typically detained for up to 2 years. How-
ever, drug addiction, particularly heroin addiction, is a
chronic condition with a high rate of relapse [4,5]. In
China, more than 90% of heroin users relapse after being
released from detoxification centers [6-9]. Therefore, it is
critical that effective interventions are identified to engage
heroin users being released from compulsory detoxifica-
tion in therapy regimens, such as methadone maintenance
treatment (MMT), in order to facilitate recovery.
Methadone treatment (either detoxification or mainten-
ance) has been the primary therapy for opiate addiction in
the United States [10]. Studies have demonstrated that
methadone treatment is clinically effective as well as
cost effective [11,12]. Specifically, MMT is effective at
decreasing heroin use, drug-related criminal behaviors,
HIV-related risk behaviors, HIV and hepatitis virus trans-
missions, and mortality among heroin addicts [13-15].
One study has shown that the probability of having an
HIV infection was approximately 6 times greater among
heroin addicts who had never received MMTas compared
to heroin addicts in an MMT program [16]. In response
to public health concerns about heroin use and heroin
use-related HIV transmission, China’s Ministry of Health
launched a national MMT program to provide methadone
treatment to heroin addicts in communities [2,16,17]. In
2004, the first eight MMT clinics were opened in the
southwestern China, and the program has since expanded
to 748 clinics in 2012. However, there are yet many bar-
riers to treatment faced by heroin users, thus the bene-
fits of China’s national MMT program will not be fully
realized unless effective means are identified to promote
engagement in treatment, and therefore, expansion of
coverage.
China’s two separate, and very different, methods for ad-
dressing the illicit drug use problem—detoxification in
detention centers governed by the Ministry of Public
Security and MMT in community clinics administered by
the Ministry of Health—highlight a serious gap in the
broader national strategies for controlling the drug use
and HIV/AIDS epidemics. Implementation of an effective
intervention to help transition heroin users released fromcompulsory detoxification centers to community-based
MMT clinics, thereby preventing their relapse and pro-
moting their rehabilitation, is urgently needed. However,
strategies for facilitating successful transition from detoxi-
fication center to treatment clinic have yet to be studied in
China.
It is within this context that we present the current
study, which examines the effectiveness of three different
referral models to determine whether any of them have
a positive impact on rates of successful referral to MMT
within six months of release from detoxification centers.
The three models examined are: referral cards plus
police-assistive MMT enrollment (Model 1), referral
cards plus 2 months of MMT in detoxification (Model
2), and referral cards only (Model 3). We hypothesize
that treating incarcerated heroin users with methadone
prior to their release will promote their enrollment and
participation in MMT after their release.
Methods
Study design and study sites
A quasi-experimental study design was used to test the
effectiveness of three different methods for referring
heroin addicts released from detoxification centers to
community-based MMT programs. Four detoxification
centers served as study sites—Luxi city, Ruili city,
Longchuan county, and Yingjiang county, all in Dehong
prefecture, Yunnan province, China. Study sites were
selected based on existing relationships between the local
government, police force, and Chinese Centers for Disease
Control and Prevention (CDC) staff to maximize the ef-
fectiveness of each intervention model. Each of the four
detoxification centers were assigned to one of three differ-
ent referral models as described in Figure 1.
Referral models
Model 1 was assigned to two detoxification centers, one in
Ruili city and one in Yingjiang county. In this model, each
subject was given one referral card and was escorted upon
release from the detoxification center to an MMT clinic
and enrolled in the MMT program by a police officer.
Model 2 was assigned to the detoxification center in Luxi
city. In this model, each subject was given MMT for two
months in the detoxification center prior to release and
then given a referral card upon release. Model 3 was
assigned to the detoxification in Longchuan county and
subjects assigned to this model were given a referral card
only. In all cases, the referral card contained the contact
information of a local MMT clinic and instructions on
how to enroll as a patient.
Study subjects
Study inclusion criteria required each participant to be
[1] a registered heroin addict detained in one of the four
Figure 1 Schematic depicting the assignment of heroin addicts released from compulsory detoxification centers to one of the three
referral strategy models examined in this study and the level of success observed in referring them to community MMT programs
after six months of follow-up.
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May 2009, [3] a legal citizen of the city/county where they
were detained, and [4] more than 18 years old. A total of
226 participants met the inclusion criteria, participated in
one of the three referral models, and were followed for six
months, from the time of their release in May 2009, to the
end of the study period in November 2009. A successful
referral was defined as a referred heroin addict being
treated in an MMTclinic for at least one month.
Study survey
Prior to commencement of the study, local Center for
Disease Control and Prevention (CDC) staff members
completed two weeks of training on interviewing and
data collection procedures. Two months prior to their
scheduled release from the detoxification centers, all
subjects participated in face-to-face interviews during
which information was collected pertaining to their
demographic characteristics, history of heroin use, prior
participation in drug addiction-related interventional
programs, and attitudes toward MMT programs.
Sample collection, HIV testing, and counseling
Immediately following the completion of interviews (two
months prior to release), venous blood samples (5 ml)
were collected from all subjects by trained local CDC staff
members. Blood collection, transportation, and laboratory
processing, as well as testing quality assurance and control
procedures were outlined in the study protocol. In brief,
all blood samples were required to be transported within12 hours of collection, all plasma samples were required
to be extracted and stored at −20°C within 12 hours of ar-
rival, and all tests were required to be conducted at la-
boratories certified by the National Center for AIDS/STD
Control and Prevention (NCAIDS).
Blood samples were screened for HIV using a rapid test
(Acon Biotech Co. Ltd, China) and positive samples were
rescreened using a different rapid test (Standard Diagnostics,
Inc., Korea). A positive result from both tests was consid-
ered to have been screened HIV-positive. All samples that
either screened HIV-positive or yielded one positive and one
negative outcome were retested using an ELISA (Kehua
Biotech Co. Ltd., China) and samples positive for HIV via
ELISA were re-tested by Western blot (MP Co. Ltd., China)
and considered confirmed HIV-positive. All tests were
performed according to the manufacturers’ instructions.
Counseling was provided onsite both before and after
testing, and all subjects were informed of their HIV sta-
tus prior to their release from the detoxification centers.
Participants who tested HIV positive were referred to
the National AIDS Program to assess their eligibility for
anti-retroviral treatment.
Statistical analysis
Baseline characteristics of the study subjects in the three
intervention model groups were compared by χ2 test and
Fisher’s exact test. To account for the site-related cluster
effect of heroin addicts released from the same detoxifica-
tion center, we conducted multilevel (detoxification center
level and individual level) logistic regression analysis that
Table 1 Selected characteristic of study participants overall and within each referral model
Characteristics
Totals Model 1: Referral cards + police
assisted MMT enrollment




P-value*N (%) N (%) N (%) N (%)
Age (years)
18 - 24 23 (10.2) 17 (15.2) 2 (3.2) 4 (7.7) 0.2237
25 - 34 122 (54.0) 57 (50.9) 34 (54.8) 31 (59.6)
35 - 44 63 (27.9) 31 (27.7) 20 (27.7) 12 (23.1)
≥ 45 18 (8.0) 7 (6.2) 6 (6.3) 5 (9.6)
Gender
Male 217 (96.0) 109 (97.3) 58 (93.5) 50 (96.2) 0.4018
Female 9 (4.0) 3 (2.7) 4 (6.5) 2 (3.8)
Ethnicity
Han 138 (61.1) 66 (58.9) 37 (59.7) 35 (67.3) 0.5719
Minority 88 (38.9) 46 (41.1) 25 (40.3) 17 (32.7)
Education level
< Primary school 121 (52.5) 56 (50.0) 28 (45.2) 37 (71.1) 0.0475
Junior high school 87 (38.5) 47 (42.0) 29 (46.8) 11 (21.2)
≥Senior high school 18 (8.0) 9 (8.0) 5 (8.0) 4 (7.7)
Marital status
Married 95 (42.0) 43 (38.4) 28 (45.2) 24 (46.2) 0.7784
Divorced or
widowed
29 (12.8) 16 (14.3) 6 (9.7) 7 (13.5)
Never married 102 (45.1) 53 (47.3) 28 (45.2) 21 (40.4)
HIV status
Positive 68 (30.1) 8 (7.1) 33 (53.2) 27 (51.9) <0.0001
Negative 158 (69.9) 104 (92.9) 29 (46.8) 25 (48.1)
History of heroin use (years)
< 1 30 (13.3) 16 (14.3) 8 (12.9) 6 (11.5) 0.0542
1-5 71 (31.4) 44 (39.3) 11 (17.7) 16 (30.8)
6-10 57 (25.2) 28 (25.0) 17 (27.4) 12 (23.1)
> 10 68 (30.1) 24 (21.4) 26 (41.9) 18 (34.6)
Prior participation in a needle-exchange program
Yes 6 (2.7) 2 (1.8) 1 (1.6) 3 (5.8) 0.3682
No 220 (97.3) 110 (98.2) 61 (98.4) 49 (94.2)
Prior participation in an MMT program
Yes 34 (15.0) 15 (13.4) 17 (27.4) 2 (3.8) 0.0017
No 192 (85.0) 97 (86.6) 45 (72.6) 50 (96.2)
Willingness to participate in an MMT program
Yes 116 (51.3) 48 (42.9) 44 (71.0) 24 (46.2) 0.0015
No 109 (48.2) 63 (56.3) 18 (29.0) 28 (53.8)
Distance from home to the nearest MMT clinic (km)
< 5 67 (29.6) 36 (32.1) 15 (24.2) 12 (23.1) 0.3619
5-10 41 (18.1) 23 (20.5) 11 (17.7) 7 (13.5)
> 10 118 (52.2) 51 (45.5) 36 (58.1) 31 (59.6)
Overall 226 (100) 112 (49.6) 62 (27.4) 52 (23.0)
*P-values were calculated by χ2 and Fisher’s exact tests.
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examine associations between referral models and the sta-
tus of successful referral. Adjusted odds ratios (ORs) and
95% confidence intervals (CIs) obtained from the adjusted
model including all covariates are reported. All p-values
are two-sided and p < 0.05 was considered statistically sig-
nificant. There were too few HIV-positive participants in
the sample to conduct a multilevel logistic regression on
this subgroup. Therefore, we used Fisher’s exact T-test to
compare the number of referrals of HIV-positive subjects
between intervention models. All statistical analyses were
performed using SAS software (Version 9.2, SAS Institute,
Cary, USA).
Ethical approval
This study was reviewed and approved by the Institute
Review Board of NCAIDS, Chinese CDC. Informed con-
sent was obtained from all participants at the time of
their enrollment in the study.
Results
A total of 226 subjects participated in this study (Table 1).
Most study participants were aged 18–34 years (64.2%),
male (96.0%), Han Chinese (61.1%), and had junior high
school-level educations or less (91.0%). Most participants
reported having used heroin for six years or more (55.3%)
and never having participated in an MMT program prior
to detention in the detoxification center (85.0%). Addition-
ally, most subjects had never participated in a needle-
exchange program (97.3%) and a large proportion tested
positive for HIV (30.1%).
Of the 226 study participants, 112 were assigned to
Model 1 (49.5%), 62 were assigned to Model 2 (27.4%), and
52 were assigned to Model 3 (23.0%). Upon comparison of
the characteristics of these three subgroups, we found that
a greater proportion of participants assigned to Model 3
had a primary school level education or less (71.1%, p <
0.0475), a lesser proportion of participants assigned to
Model 1 had an HIV-positive serostatus (7.1%, p < 0.0001),
and a greater proportion of participants assigned to Model
2 reported being willing to participate in an MMT program
(71.0%). No other factors were found to differ significantly
between the three subgroups (Table 1).
As shown in Table 2, a total of 22 participants (9.7%)
were successfully referred to a community-based MMT
program within six months of their release from detoxifi-
cation centers. Six successful referrals (5.4%) were facili-
tated by Model 1, sixteen (25.8%) by Model 2, and zero
by Model 3. The highest rate of successful referral was
achieved with Model 2, subjects assigned to this model
received MMT for a median of 83 days (mean = 87 days)
during six months of follow-up.
The results of multilevel logistic regression analysis
are summarized in Table 2. Compared with Model 1,Model 2 was associated with increased odds of success-
ful referral (adjusted OR = 1.2, CI = 1.1-1.3), and Model
3 did not different from Model 1. Prior MMT treatment
was the only variable examined that was found to be as-
sociated with an increased likelihood of successful refer-
ral to MMT (adjusted OR = 1.5, CI = 1.3-1.6).
The overall rate of successful referral was greater
among HIV-positive subjects (11 out of 68, 16.2%) com-
pared to HIV-negative subjects (11 out of 158, 7.0%,
Table 1). Comparison of successful referral rates among
the 68 HIV-positive participants is shown in Table 3. The
rate of successful referral to MMT was 25.0% for Model 1,
27.3% for Model 2, and 0% for Model 3.Discussion
A large proportion of China’s heroin addicts are incarcer-
ated in compulsory detoxification centers where metha-
done treatment is unavailable [9]. Once released from
these centers, relapse rates are estimated to be greater
than 90% [6-9]. The probability of acquiring HIV is con-
sidered high in this population, due to high-risk, drug use-
related injecting and sexual behaviors, both inside and
outside of detoxification centers [9]. Expansion of metha-
done treatment coverage to include recently-released her-
oin addicts is critical to harm reduction in this population.
However, effective interventions aimed at improving refer-
ral to community-based MMT clinics for newly-released
prisoners in China are lacking.
This study evaluated the effectiveness of three referral
models at successfully transitioning heroin users from
compulsory detoxification to MMT participation. Findings
show that use of a referral model that incorporates metha-
done treatment for heroin addicts while they are still
incarcerated increases the probability of their enrollment
and participation in MMT after their release. Adjusted
analyses indicate that prior experience with methadone is
the only study variable associated with increased odds of
successful MMT referral. These results have important
implications for both heroin addiction treatment and HIV
transmission prevention in China, as they suggest that
treating incarcerated heroin users with methadone prior
to their release may promote their subsequent enrollment
and participation in MMT. Additional research among
heroin users from different regions in China is needed to
further confirm the effectiveness of this referral card plus
MMT intervention in increasing transition from a detoxi-
fication center to MMT enrollment and participation.
A lager sample will be required to elucidate the severity
(e.g., level of heroin use, HIV status) or enabling (e.g.,
perceived effectiveness of prior MMT or attitudinal
changes after MMT) factors that may mediate or explain
the association between prior MMT use and subsequent
MMT participation.







P-valueN (%) n (%) (n/N,%) OR (CI) OR (CI)
Referral strategy
Model 1: Referral Cards + Police-Assisted MMT Enrollment 112 (49.6) 6 (27.3) 5.4 1.0 1.0
Model 2: Referral Cards + 2 Months MMT in Detoxification 62 (27.4) 16 (72.7) 25.8 1.2 (1.1-1.4) 1.2 (1.1-1.3) 0.0023
Model 3: Referral Cards Only 52 (23.0) 0 (0.0) 0.0 0.95 (0.83-1.1) 0.99 (0.90-1.1) 0.0757
Baseline covariates
Age (years)
18 - 24 23 (10.2) 0 (0.0) 0.0 1.0 1.0 -
25 - 34 122 (54.0) 13 (59.1) 10.7 0.97 (0.81-1.2) 1.0 (0.84-1.2) 0.9966
35 - 44 63 (27.9) 9 (40.9) 14.3 1.1 (0.97-1.3) 1.1 (0.96-1.3) 0.1662
≥ 45 18 (8.0) 0 (0.0) 0.0 0.97 (0.81-1.2) 1.0 (0.84-1.2) 0.9966
Gender
Female 9 (4.0) 0 (0.0) 0.0 1.0 1.0 -
Male 217 (96.0) 22 (100) 10.1 1.2 (0.96-1.4) 0.96 (0.81-1.1) 0.6477
Ethnicity
Minority 88 (38.9) 13 (59.1) 14.8 1.0 1.0 -
Han 138 (61.1) 9 (40.9) 6.5 0.93 (0.86-1.0) 0.96 (0.90-1.0) 0.2631
Education level
< Primary school 121 (52.5) 5 (22.7) 4.1 1.0 1.0 -
Junior high school 87 (38.5) 13 (59.1) 14.9 1.1 (1.0-1.2) 1.0 (0.95-1.1) 0.6598
≥ Senior high school 18 (8.0) 4 (18.2) 22.2 1.2 (1.0-1.4) 1.1 (0.92-1.2) 0.4434
Marital status
Never married 102 (45.1) 16 (72.7) 15.7 1.0 1.0 -
Married 95 (42.0) 5 (22.7) 5.3 0.90 (0.83-0.97) 0.94 (0.87-1.0) 0.1041
Divorced or widowed 29 (12.8) 1 (4.5) 3.4 0.89 (0.80-1.0) 0.91 (0.81-1.0) 0.0932
HIV status
Negative 158 (69.9) 11 (50.0) 7.0 1.0 1.0 -
Positive 68 (30.1) 11 (50.0) 16.2 0.94 (0.86-1.0) 0.98 (0.90-1.1) 0.6770
History of heroin use (years)
< 1 30 (13.3) 0 (0.0) 0.0 1.0 1.0 -
1-5 71 (31.4) 3 (13.6) 4.2 1.1 (1.0-1.3) 1.0 (0.93-1.2) 0.4783
6-10 57 (25.2) 9 (40.9) 15.8 1.2 (1.0-1.3) 1.0 (0.93-1.2) 0.4948
> 10 68 (30.1) 10 (45.5) 14.7 1.1 (1.0-1.3) 1.0 (0.93-1.2) 0.4783
Prior participation in a needle-exchange program
No 220 (97.3) 21 (95.5) 9.5 1.0 1.0 -
Yes 6 (2.7) 1 (4.5) 16.7 1.1 (0.90-1.4) 1.2 (0.97-1.5) 0.0880
Prior participation in an MMT program 0.0
No 192 (85.0) 5 (22.7) 2.6 1.0 1.0 -
Yes 34 (15.0) 17 (77.3) 50.0 1.6 (1.4-1.7) 1.5 (1.3-1.6) <0.0001
Willingness to participate in an MMT program
No 109 (48.2) 6 (27.3) 5.5 1.0 1.0 -
Yes 116 (51.3) 16 (72.7) 13.8 1.0 (0.97-1.1) 0.98 (0.92-1.1) 0.6527
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Table 2 Comparisons of the three referral models during six months of follow-up (Continued)
Distance from home to the nearest MMT clinic (km)
> 10 118 (52.2) 5 (22.7) 4.2 1.0 1.0 -
5-10 41 (18.1) 5 (22.7) 12.2 1.1 (0.98-1.1) 1.1 (0.96-1.1) 0.2565
< 5 67 (29.6) 12 (54.5) 17.9 1.2 (1.1-1.3) 1.0 (0.95-1.1) 0.4387
Overall 226 (100.0) 22 (100.0) 9.7 - - -
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of-treatment heroin addicts face many barriers to entry
into MMT programs, including a long waiting list, lack
of money or health insurance, beliefs about methadone’s
real or rumored side effects, and fear of addiction to or
later withdrawal from methadone [18-20]. Such barriers
also are reported to exist for China’s opiate addicts [21].
Hence, interventions aimed at reducing or eliminating
these barriers are urgently needed. Our results suggest that
prior methadone treatment experience might help heroin
users overcome some of these barriers, as demonstrated by
the much higher proportion of successful referrals among
heroin users in the referral card plus MMT while in de-
toxification intervention model (25.8%). However, China’s
detoxification centers and prisons presently do not allow
their detainees to receive methadone treatment despite the
fact that both the World Health Organization and the
United Nations Office on Drugs and Crime recommend
use of opiate replacement treatment for heroin addicts in
prison systems [22]. That said, China is not the only coun-
try that does not follow this guidance—at present only 29
countries, most of which are in Europe, provide opiate re-
placement therapy in their prison systems [22,23].
Unfortunately, heroin addicts in prison continue to be at
high risk of acquiring blood-borne infections [24-27]. One
study conducted in China has shown that injecting drug
use behaviors are present among heroin addicts in detoxi-
fication centers [28]. Although it cannot be determined
from the data whether HIV infections occurred prior to orTable 3 Comparisons of three referral models during six










value*N (%) n (%) (n/N,%)
Model 1: Referral Cards +
Police-assisted
MMT enrollment
8 (11.8) 2 (18.2) 25.0 0.0048
Model 2: Referral cards + 2
months MMT in
detoxification
33 (48.5) 9 (81.8) 27.3
Model 3: Referral cards only 27 (39.7) 0 (0) 0
Overall 68 (100.0) 11 (100.0) 16.2 -
*Fischer’s exact t-test was used because of the small sample size.during their terms in the detoxification centers, a relatively
high proportion (30.1%) of participants in this study were
HIV-positive. The high prevalence of HIV infection
coupled with possible drug-related risk behaviors all point
to a need for including addiction treatment (e.g., MMT) in
detoxification centers. Of note, a higher proportion of
HIV-positive heroin addicts (16.2%) were successfully
referred to MMT as compared to HIV-negative subjects
(7.0%) in our study. Although this result is descriptive
and based on a small sample of HIV-positive participants
(n = 68), it provides some evidence upon which future re-
search studies can be based to test and refine referral
models aiming to improve engagement in MMT after de-
toxification center release.
This study has several limitations. First, the sample size
is small and the study sites are limited to Dehong prefec-
ture. Therefore, the generalizability of this study may be
limited. Second, we only examined whether heroin addicts
successfully enrolled and participated in MMT. Some pro-
portions of those who did not may have engaged in needle
exchange programs or other treatment programs, such as
buprenorphine treatment. Third, the intervention was not
randomly assigned to detoxification centers, therefore the
baseline characteristics of study subjects in the three inter-
vention models were not balanced. Although our analyses
adjusted for characteristics that differed across centers, we
may not have been able to balance out all site-related dif-
ferences. Thus, some selection bias may have remained.
Fourth, there might some other important factors that
could influence successful referral such as family supports
were not collect by this study.
Conclusion
In summary, these results provide important new evi-
dence for the beneficial effect of prior methadone ex-
perience in promoting the successful MMT enrollment
and participation by heroin addicts released from China’s
compulsory detoxification centers. These data lend some
support for establishing collaboration between China’s
Ministry of Public Security and Ministry of Health to ex-
pand methadone treatment coverage such that detainees
can be treated both during their sentences and after
their release, which will not only prevent their likely re-
lapse, but promote their rehabilitation, protect them
from HIV infection, and increase their survival.
Yan et al. BMC Public Health 2013, 13:747 Page 8 of 8
http://www.biomedcentral.com/1471-2458/13/747Competing interest
The authors declare that they have no competing interests.
Authors’ contributions
LY and ZW designed the study. LY, SD and ZW implemented the study. EL
conducted data analysis. LY, EL, JMM, LW, SC, and ZW interpreted data and
authored and edited the manuscript. All authors read and approved the final
manuscript.
Acknowledgements
The authors would like to thank staff of the Dehong Prefecture CDC, Yunnan
Province, China.
Funding
This study was supported by the US Center for Disease Control and
Prevention, Global AIDS Program, China (5U2GPS001188-03), the Fogarty
International Center, National Institute on Drug Abuse, the United States
National Institutes of Health (Grant #5U2RTW006918-08). Funding
organizations had no role in the design of this study, in the collection,
analysis, or interpretation of data, or in the final decision to submit the
manuscript for publication. The contents of this paper are solely the
responsibility of the authors and do not necessarily represent the official
views of the authors institutions of affiliation.
Author details
1National Center for AIDS/STD Control and Prevention, Chinese Center for
Disease Control and Prevention, Beijing, China. 2Beijing Haidian District
Health School, Beijing, China. 3Dehong Prefecture Center for Disease Control
and Prevention, Yunnan Province, China. 4Department of Psychiatry and
Behavioral Science, Duke University Medical Center, Durham, NC 27710, USA.
5UCLA Center for Community Health, Los Angeles, CA 90024, USA.
Received: 16 February 2013 Accepted: 3 August 2013
Published: 13 August 2013
References
1. Wang L: Overview of the HIV/AIDS epidemic, scientific research and
government responses in China. AIDS 2007, 21(Suppl 8):S3–7.
2. Wu Z, Sullivan S, Wang Y, Rotheram-Borus M, Detels R: Evolution of China’s
response to HIV/AIDS. Lancet 2007, 369(9562):679–690.
3. National Narcotics Control Commission: Annual Report on Drug Control in
China 2011. Beijing; 2011.
4. Weiss F: Neurobiology of craving, conditioned reward and relapse.
Curr Opin Pharmacol 2005, 5(1):9–19.
5. Wu LT, Woody GE, Yang C, Mannelli P, Blazer DG: Differences in onset and
abuse/dependence episodes between prescription opioids and heroin:
results from the national epidemiologic survey on alcohol and related
conditions. Subst Abuse Rehabil 2011, 2011(2):77–88.
6. Sun B, Ye Y, Qin L: An analysis of relapse factors of 615 heroin addicts.
Chin J Drug Dependence 2001, 10(3):214–216.
7. Tie E, Zeng H, Jin J, Xu B, Sun Z, Wang Y: An epidemic investigation on
relapse and relapse reasons after detoxification. Chin J Drug Dependence
1999, 8(4):305–309.
8. Wang H, Pu D: An analysis of relapse factors of opioid addicts. Chin J
Drug Abuse Prev Treat 2004, 10(2):85–87.
9. Sullivan SG, Wu Z: Rapid scale up of harm reduction in China. Int J Drug
Policy 2007, 18(2):118–128.
10. Substance Abuse and Mental Health Services Administration Office of
Applied Studies: Substance Abuse and Mental Health Services Administration.
The N-SSATS Report: Overview of Opioid Treatment Programs within the United
States: 2008. Rockville, MD; 2010.
11. Marsch LA: The efficacy of methadone maintenance interventions in
reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis.
Addiction 1998, 93(4):515–532.
12. McCarty D, Perrin NA, Green CA, Polen MR, Leo MC, Lynch F: Methadone
maintenance and the cost and utilization of health care among
individuals dependent on opioids in a commercial health plan.
Drug Alcohol Depend 2010, 111(3):235–240.
13. Thiede H, Hagan H, Murrill CS: Methadone treatment and HIV and
hepatitis B and C risk reduction among injectors in the Seattle area.
J Urban Health 2000, 77(3):331–345.14. McCowan C, Kidd B, Fahey T: Factors associated with mortality in Scottish
patients receiving methadone in primary care: retrospective cohort
study. BMJ 2009, 338:b2225.
15. Lind B, C.S, Weatherburn D, Mattick R: The effectiveness of methadone
maintenance treatment in controlling crime. Br J Criminol 2005, 45:201–211.
16. Rich JD, McKenzie M, Shield DC, Wolf FA, Key RG, Poshkus M: Linkage with
methadone treatment upon release from incarceration: a promising
opportunity. J Addict Dis 2005, 24(3):49–59.
17. Meise M, Wang X, Sauter ML, Bao YP, Shi J, Liu ZM: Harm reduction for
injecting opiate users: an update and implications in China.
Acta Pharmacol Sin 2009, 30(5):513–521.
18. Peterson JA, Schwartz RP, Mitchell SG, Reisinger HS, Kelly SM, O'Grady KE:
Why don’t out-of-treatment individuals enter methadone treatment
programmes? Int J Drug Policy, 21(1):36–42.
19. Sheridan J, Goodyear-Smith F, Butler R, Wheeler A, Gohns A: Barriers to,
and incentives for, the transfer of opioid-dependent people on
methadone maintenance treatment from secondary care to primary
health care. Drug Alcohol Rev 2008, 27(2):178–184.
20. Callon C, Wood E, Marsh D, Li K, Montaner J, Kerr T: Barriers and facilitators
to methadone maintenance therapy use among illicit opiate injection
drug users in Vancouver. J Opioid Manag 2006, 2(1):35–41.
21. Lin C, Wu Z, Detels R: Opiate users’ perceived barriers against attending
methadone maintenance therapy: a qualitative study in China. Subst Use
Misuse 2011, 46(9):1190–1198.
22. Larney S, Dolan K: A literature review of international implementation of
opioid substitution treatment in prisons: equivalence of care? Eur Addict
Res 2009, 15(2):107–112.
23. Mathers BM, Degenhardt L, Ali H, Wiessing L, Hickman M, Mattick RP: HIV
prevention, treatment, and care services for people who inject drugs: a
systematic review of global, regional, and national coverage. Lancet 2010,
375(9719):1014–1028.
24. Taylor A, Goldberg D, Emslie J, Wrench J, Gruer L, Cameron S: Outbreak of
HIV infection in a Scottish prison. BMJ 1995, 310(6975):289–292.
25. Goldberg D, Taylor A, McGregor J, Davis B, Wrench J, Gruer L: A lasting
public health response to an outbreak of HIV infection in a Scottish
prison? Int J STD AIDS 1998, 9(1):25–30.
26. Farnia M, Ebrahimi B, Shams A, Zamani S: Scaling up methadone maintenance
treatment for opioid-dependent prisoners in Iran. Int J Drug Policy.
27. Wolfe MI, Xu F, Patel P, O'Cain M, Schillinger JA, St Louis ME: An outbreak
of syphilis in Alabama prisons: correctional health policy and
communicable disease control. Am J Public Health 2001, 91(8):1220–1225.
28. Yan L, Duan S, Gong Yu R, Yang Y, Xiang L, Ye R, Pang L, Liu E, Wu Z: An
evaluation study on HIV risk behaviors and infections in four detoxification
centers in Yunnan provice of China. Chin J AIDS STD 2010, 16(2):149–151. 156.
doi:10.1186/1471-2458-13-747
Cite this article as: Yan et al.: Referring heroin users from compulsory
detoxification centers to community methadone maintenance
treatment: a comparison of three models. BMC Public Health 2013 13:747.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
